Abstract
Summary
Generic injections are injections that have the same active ingredients, the same dosage, the same route of administration, the same dosage form, and the same indications as the original drug.
The global market for Generic Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Generic Injection, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Generic Injection by region & country, by Type, and by Application.
The Generic Injection market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Injection.
Market Segmentation
By Company
Sanofi
Fresenius
Viatris
Pfizer
Teva Pharmaceuticals
Hikma Pharmaceuticals
Novartis
Amneal Pharmaceuticals
Gland Pharma
Allergan
Kelun Pharmaceutical
Jiangsu HRS
Qilu Pharmaceutical
Chiatai Tianqing
Hainan Poly Pharm
Yangzijiang Pharmaceutical Industry
Shijiazhuang Pharma Group
Segment by Type:
Liquid Injection
Powder for Injection
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Generic Injection manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Generic Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Generic Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Generic Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Generic Injection, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Generic Injection by region & country, by Type, and by Application.
The Generic Injection market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Injection.
Market Segmentation
By Company
Sanofi
Fresenius
Viatris
Pfizer
Teva Pharmaceuticals
Hikma Pharmaceuticals
Novartis
Amneal Pharmaceuticals
Gland Pharma
Allergan
Kelun Pharmaceutical
Jiangsu HRS
Qilu Pharmaceutical
Chiatai Tianqing
Hainan Poly Pharm
Yangzijiang Pharmaceutical Industry
Shijiazhuang Pharma Group
Segment by Type:
Liquid Injection
Powder for Injection
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Generic Injection manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Generic Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Generic Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Generic Injection Product Introduction
1.2 Global Generic Injection Market Size Forecast
1.3 Generic Injection Market Trends & Drivers
1.3.1 Generic Injection Industry Trends
1.3.2 Generic Injection Market Drivers & Opportunity
1.3.3 Generic Injection Market Challenges
1.3.4 Generic Injection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Generic Injection Players Revenue Ranking (2023)
2.2 Global Generic Injection Revenue by Company (2019-2024)
2.3 Key Companies Generic Injection Manufacturing Base Distribution and Headquarters
2.4 Key Companies Generic Injection Product Offered
2.5 Key Companies Time to Begin Mass Production of Generic Injection
2.6 Generic Injection Market Competitive Analysis
2.6.1 Generic Injection Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Generic Injection Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injection as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Liquid Injection
3.1.2 Powder for Injection
3.2 Global Generic Injection Sales Value by Type
3.2.1 Global Generic Injection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Generic Injection Sales Value, by Type (2019-2030)
3.2.3 Global Generic Injection Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Generic Injection Sales Value by Application
4.2.1 Global Generic Injection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Generic Injection Sales Value, by Application (2019-2030)
4.2.3 Global Generic Injection Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Generic Injection Sales Value by Region
5.1.1 Global Generic Injection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Generic Injection Sales Value by Region (2019-2024)
5.1.3 Global Generic Injection Sales Value by Region (2025-2030)
5.1.4 Global Generic Injection Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Generic Injection Sales Value, 2019-2030
5.2.2 North America Generic Injection Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Generic Injection Sales Value, 2019-2030
5.3.2 Europe Generic Injection Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Generic Injection Sales Value, 2019-2030
5.4.2 Asia Pacific Generic Injection Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Generic Injection Sales Value, 2019-2030
5.5.2 South America Generic Injection Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Generic Injection Sales Value, 2019-2030
5.6.2 Middle East & Africa Generic Injection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Generic Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Generic Injection Sales Value
6.3 United States
6.3.1 United States Generic Injection Sales Value, 2019-2030
6.3.2 United States Generic Injection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Generic Injection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Generic Injection Sales Value, 2019-2030
6.4.2 Europe Generic Injection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Generic Injection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Generic Injection Sales Value, 2019-2030
6.5.2 China Generic Injection Sales Value by Type (%), 2023 VS 2030
6.5.3 China Generic Injection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Generic Injection Sales Value, 2019-2030
6.6.2 Japan Generic Injection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Generic Injection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Generic Injection Sales Value, 2019-2030
6.7.2 South Korea Generic Injection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Generic Injection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Generic Injection Sales Value, 2019-2030
6.8.2 Southeast Asia Generic Injection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Generic Injection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Generic Injection Sales Value, 2019-2030
6.9.2 India Generic Injection Sales Value by Type (%), 2023 VS 2030
6.9.3 India Generic Injection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Profile
7.1.2 Sanofi Main Business
7.1.3 Sanofi Generic Injection Products, Services and Solutions
7.1.4 Sanofi Generic Injection Revenue (US$ Million) & (2019-2024)
7.1.5 Sanofi Recent Developments
7.2 Fresenius
7.2.1 Fresenius Profile
7.2.2 Fresenius Main Business
7.2.3 Fresenius Generic Injection Products, Services and Solutions
7.2.4 Fresenius Generic Injection Revenue (US$ Million) & (2019-2024)
7.2.5 Fresenius Recent Developments
7.3 Viatris
7.3.1 Viatris Profile
7.3.2 Viatris Main Business
7.3.3 Viatris Generic Injection Products, Services and Solutions
7.3.4 Viatris Generic Injection Revenue (US$ Million) & (2019-2024)
7.3.5 Pfizer Recent Developments
7.4 Pfizer
7.4.1 Pfizer Profile
7.4.2 Pfizer Main Business
7.4.3 Pfizer Generic Injection Products, Services and Solutions
7.4.4 Pfizer Generic Injection Revenue (US$ Million) & (2019-2024)
7.4.5 Pfizer Recent Developments
7.5 Teva Pharmaceuticals
7.5.1 Teva Pharmaceuticals Profile
7.5.2 Teva Pharmaceuticals Main Business
7.5.3 Teva Pharmaceuticals Generic Injection Products, Services and Solutions
7.5.4 Teva Pharmaceuticals Generic Injection Revenue (US$ Million) & (2019-2024)
7.5.5 Teva Pharmaceuticals Recent Developments
7.6 Hikma Pharmaceuticals
7.6.1 Hikma Pharmaceuticals Profile
7.6.2 Hikma Pharmaceuticals Main Business
7.6.3 Hikma Pharmaceuticals Generic Injection Products, Services and Solutions
7.6.4 Hikma Pharmaceuticals Generic Injection Revenue (US$ Million) & (2019-2024)
7.6.5 Hikma Pharmaceuticals Recent Developments
7.7 Novartis
7.7.1 Novartis Profile
7.7.2 Novartis Main Business
7.7.3 Novartis Generic Injection Products, Services and Solutions
7.7.4 Novartis Generic Injection Revenue (US$ Million) & (2019-2024)
7.7.5 Novartis Recent Developments
7.8 Amneal Pharmaceuticals
7.8.1 Amneal Pharmaceuticals Profile
7.8.2 Amneal Pharmaceuticals Main Business
7.8.3 Amneal Pharmaceuticals Generic Injection Products, Services and Solutions
7.8.4 Amneal Pharmaceuticals Generic Injection Revenue (US$ Million) & (2019-2024)
7.8.5 Amneal Pharmaceuticals Recent Developments
7.9 Gland Pharma
7.9.1 Gland Pharma Profile
7.9.2 Gland Pharma Main Business
7.9.3 Gland Pharma Generic Injection Products, Services and Solutions
7.9.4 Gland Pharma Generic Injection Revenue (US$ Million) & (2019-2024)
7.9.5 Gland Pharma Recent Developments
7.10 Allergan
7.10.1 Allergan Profile
7.10.2 Allergan Main Business
7.10.3 Allergan Generic Injection Products, Services and Solutions
7.10.4 Allergan Generic Injection Revenue (US$ Million) & (2019-2024)
7.10.5 Allergan Recent Developments
7.11 Kelun Pharmaceutical
7.11.1 Kelun Pharmaceutical Profile
7.11.2 Kelun Pharmaceutical Main Business
7.11.3 Kelun Pharmaceutical Generic Injection Products, Services and Solutions
7.11.4 Kelun Pharmaceutical Generic Injection Revenue (US$ Million) & (2019-2024)
7.11.5 Kelun Pharmaceutical Recent Developments
7.12 Jiangsu HRS
7.12.1 Jiangsu HRS Profile
7.12.2 Jiangsu HRS Main Business
7.12.3 Jiangsu HRS Generic Injection Products, Services and Solutions
7.12.4 Jiangsu HRS Generic Injection Revenue (US$ Million) & (2019-2024)
7.12.5 Jiangsu HRS Recent Developments
7.13 Qilu Pharmaceutical
7.13.1 Qilu Pharmaceutical Profile
7.13.2 Qilu Pharmaceutical Main Business
7.13.3 Qilu Pharmaceutical Generic Injection Products, Services and Solutions
7.13.4 Qilu Pharmaceutical Generic Injection Revenue (US$ Million) & (2019-2024)
7.13.5 Qilu Pharmaceutical Recent Developments
7.14 Chiatai Tianqing
7.14.1 Chiatai Tianqing Profile
7.14.2 Chiatai Tianqing Main Business
7.14.3 Chiatai Tianqing Generic Injection Products, Services and Solutions
7.14.4 Chiatai Tianqing Generic Injection Revenue (US$ Million) & (2019-2024)
7.14.5 Chiatai Tianqing Recent Developments
7.15 Hainan Poly Pharm
7.15.1 Hainan Poly Pharm Profile
7.15.2 Hainan Poly Pharm Main Business
7.15.3 Hainan Poly Pharm Generic Injection Products, Services and Solutions
7.15.4 Hainan Poly Pharm Generic Injection Revenue (US$ Million) & (2019-2024)
7.15.5 Hainan Poly Pharm Recent Developments
7.16 Yangzijiang Pharmaceutical Industry
7.16.1 Yangzijiang Pharmaceutical Industry Profile
7.16.2 Yangzijiang Pharmaceutical Industry Main Business
7.16.3 Yangzijiang Pharmaceutical Industry Generic Injection Products, Services and Solutions
7.16.4 Yangzijiang Pharmaceutical Industry Generic Injection Revenue (US$ Million) & (2019-2024)
7.16.5 Yangzijiang Pharmaceutical Industry Recent Developments
7.17 Shijiazhuang Pharma Group
7.17.1 Shijiazhuang Pharma Group Profile
7.17.2 Shijiazhuang Pharma Group Main Business
7.17.3 Shijiazhuang Pharma Group Generic Injection Products, Services and Solutions
7.17.4 Shijiazhuang Pharma Group Generic Injection Revenue (US$ Million) & (2019-2024)
7.17.5 Shijiazhuang Pharma Group Recent Developments
8 Industry Chain Analysis
8.1 Generic Injection Industrial Chain
8.2 Generic Injection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Generic Injection Sales Model
8.5.2 Sales Channel
8.5.3 Generic Injection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer